Sanofi SA (SASY.PA)
PARIS/CHICAGO The World Health Organization (WHO) said on Thursday Sanofi's vaccine against dengue should only be used after testing on individuals to assess whether they have ever been exposed to the infection.
* Sanofi confident in vaccine's safety (Changes headline, adds Sanofi comment)
* SANOFI SAYS CONFIDENT IN DENGVAXIA’S SAFETY AND PROVEN POTENTIAL TO REDUCE DENGUE DISEASE BURDEN IN ENDEMIC COUNTRIES
PARIS Sanofi's executive vice president and chief financial officer, Jerome Contamine, plans to retire later this year, the French drugmaker said on Tuesday.
PARIS, April 17 Sanofi's executive vice president and chief financial officer, Jerome Contamine, plans to retire later this year, the French drugmaker said on Tuesday.
PARIS French healthcare group Sanofi is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent International for 1.9 billion euros ($2.4 billion), the companies said on Tuesday. | Video
LONDON, April 17 (LPC) - Goldman Sachs, JP Morgan and Morgan Stanley are expected to lead a debt financing totalling in excess of €1bn backing private equity firm Advent International’s acquisition of French healthcare group Sanofi’s European generics drugs arm Zentiva, banking sources said.
* Healthcare sector has seen lots of M&A so far in 2018 (Adds detail)
PARIS, April 17 French healthcare group Sanofi has started exclusive talks with private equity firm Advent International over selling its Zentiva European generics drugs arm to Advent for 1.9 billion euros ($2.4 billion), the companies said.
PARIS French healthcare and drugs group Sanofi has agreed to sell a portfolio of 12 pharmaceutical brands to Charterhouse Capital Partners' Cooper-Vemedia drugs manufacturing arm for 158 million euros ($195 million), the companies said on Monday.